GlassScriptPhysician profile
David William Goodman
NPI 1548411564
$40,651.77
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,314 · 2020: $2,689 · 2021: $18K · 2023: $16K · 2024: $70.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $1,704 · Food and Beverage: $875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,764.00 |
| Travel and Lodging | $1,703.56 |
| Food and Beverage | $875.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $9,024.31 | 2020-2023 | Jornay Pm |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $7,406.29 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $6,170.00 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $6,031.46 | 2019-2021 | |
| Noven Pharmaceuticals, INC. | $4,248.00 | 2021 | |
| Shire North American Group INC | $3,220.00 | 2019 | |
| Tris Pharma INC | $3,000.00 | 2021 | |
| Shionogi INC | $1,350.00 | 2021 | |
| Palette Life Sciences, INC. | $131.09 | 2021 | |
| Supreme Orthopedic Systems, LLC | $47.60 | 2024 | |
| Mimedx Group, INC. | $23.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.